Serum levels of receptors for advanced glycation end products in normal-weight and obese children born small and large for gestational age

21Citations
Citations of this article
46Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

OBJECTIVE - To assess potential alterations in soluble and endogenous secretory receptors for advanced glycation end products (sRAGE and esRAGE) in normal-weight (NW) and obese (Ob) children born small (SGA) and large (LGA) compared with appropriate for gestational age (AGA) subjects and to explore if birth weight (BW), insulin resistance (IR), and obesity represent independent risk factors. RESEARCH DESIGN AND METHODS - We categorized 130 prepubertal children into six groups according to BW and obesity and evaluated sRAGE, esRAGE, and homeostasis model assessment of IR. RESULTS - sRAGE and esRAGE were lower in Ob SGA and LGA children than Ob AGA subjects (all P < 0.05), and in NW SGA and LGA children than NW AGA subjects (all P < 0.05). Interestingly, BW and IR were significantly and independently related to RAGE. CONCLUSIONS - sRAGE and esRAGE are decreased in SGA and LGA children, and BW and IR seem to play an important role in the reduction of RAGE. © 2012 by the American Diabetes Association.

Cite

CITATION STYLE

APA

Chiavaroli, V., D’Adamo, E., Giannini, C., De Giorgis, T., De Marco, S., Chiarelli, F., & Mohn, A. (2012). Serum levels of receptors for advanced glycation end products in normal-weight and obese children born small and large for gestational age. Diabetes Care, 35(6), 1361–1363. https://doi.org/10.2337/dc11-2302

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free